Literature DB >> 19003161

smyd1 and smyd2 are expressed in muscle tissue in Xenopus laevis.

Shinobu Kawamura1, Emi Yoshigai, Satoru Kuhara, Kosuke Tashiro.   

Abstract

Epigenetic modifications of histone play important roles for regulation of cell activity, such as cell division, cell death, and cell differentiation. A SET domain consisting of about 130 amino acids has lysine methyltransferase activity in the presence of the cosubstrate S-adenosyl-methionine. More than 60 SET domain-containing proteins have been predicted in various organisms. One of them, the SMYD family genes which contain a SET domain and a zinc-finger MYND domain are reported to regulate cell cycle and muscle formation. Here we examined the expression and function of smyd1 and 2 in Xenopus. smyd1 and 2 were expressed in various muscle tissues. While smyd1 expression was observed mainly in cardiac muscle and skeletal muscle, smyd2 expression was done abundantly in skeletal muscle and face region. Moreover, by loss-of-function experiments using antisense morpholino oligonucleotides, it was suggested that smyd1 and 2 related to muscle cells differentiation.

Entities:  

Year:  2008        PMID: 19003161      PMCID: PMC2553668          DOI: 10.1007/s10616-008-9128-1

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  35 in total

1.  A variable number of tandem repeats polymorphism in an E2F-1 binding element in the 5' flanking region of SMYD3 is a risk factor for human cancers.

Authors:  Masataka Tsuge; Ryuji Hamamoto; Fabio Pittella Silva; Yozo Ohnishi; Kazuaki Chayama; Naoyuki Kamatani; Yoichi Furukawa; Yusuke Nakamura
Journal:  Nat Genet       Date:  2005-09-11       Impact factor: 38.330

2.  The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation.

Authors:  Giuseppina Caretti; Monica Di Padova; Bruce Micales; Gary E Lyons; Vittorio Sartorelli
Journal:  Genes Dev       Date:  2004-11-01       Impact factor: 11.361

3.  MLL, a mammalian trithorax-group gene, functions as a transcriptional maintenance factor in morphogenesis.

Authors:  B D Yu; R D Hanson; J L Hess; S E Horning; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 4.  SET domain proteins modulate chromatin domains in eu- and heterochromatin.

Authors:  T Jenuwein; G Laible; R Dorn; G Reuter
Journal:  Cell Mol Life Sci       Date:  1998-01       Impact factor: 9.261

5.  The Bop gene adjacent to the mouse CD8b gene encodes distinct zinc-finger proteins expressed in CTLs and in muscle.

Authors:  I Hwang; P D Gottlieb
Journal:  J Immunol       Date:  1997-02-01       Impact factor: 5.422

6.  Cytochalasin B inhibits morphogenetic movement and muscle differentiation of activin-treated ectoderm in Xenopus.

Authors:  K Tamai; C Yokota; T Ariizumi; M Asashima
Journal:  Dev Growth Differ       Date:  1999-02       Impact factor: 2.053

7.  Regulation of p53 activity through lysine methylation.

Authors:  Sergei Chuikov; Julia K Kurash; Jonathan R Wilson; Bing Xiao; Neil Justin; Gleb S Ivanov; Kristine McKinney; Paul Tempst; Carol Prives; Steven J Gamblin; Nickolai A Barlev; Danny Reinberg
Journal:  Nature       Date:  2004-11-03       Impact factor: 49.962

8.  BOP, a regulator of right ventricular heart development, is a direct transcriptional target of MEF2C in the developing heart.

Authors:  Dillon Phan; Tara L Rasmussen; Osamu Nakagawa; John McAnally; Paul D Gottlieb; Philip W Tucker; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Development       Date:  2005-06       Impact factor: 6.868

9.  Altered Hox expression and segmental identity in Mll-mutant mice.

Authors:  B D Yu; J L Hess; S E Horning; G A Brown; S J Korsmeyer
Journal:  Nature       Date:  1995-11-30       Impact factor: 49.962

10.  SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells.

Authors:  Ryuji Hamamoto; Yoichi Furukawa; Masashi Morita; Yuko Iimura; Fabio Pittella Silva; Meihua Li; Ryuichiro Yagyu; Yusuke Nakamura
Journal:  Nat Cell Biol       Date:  2004-07-04       Impact factor: 28.824

View more
  12 in total

1.  Structure of human SMYD2 protein reveals the basis of p53 tumor suppressor methylation.

Authors:  Li Wang; Ling Li; Hailong Zhang; Xiao Luo; Jingquan Dai; Shaolian Zhou; Justin Gu; Jidong Zhu; Peter Atadja; Chris Lu; En Li; Kehao Zhao
Journal:  J Biol Chem       Date:  2011-08-31       Impact factor: 5.157

2.  Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization.

Authors:  Laura T Donlin; Christian Andresen; Steffen Just; Eugene Rudensky; Christopher T Pappas; Martina Kruger; Erica Y Jacobs; Andreas Unger; Anke Zieseniss; Marc-Werner Dobenecker; Tobias Voelkel; Brian T Chait; Carol C Gregorio; Wolfgang Rottbauer; Alexander Tarakhovsky; Wolfgang A Linke
Journal:  Genes Dev       Date:  2012-01-12       Impact factor: 11.361

3.  Function of the MYND Domain and C-Terminal Region in Regulating the Subcellular Localization and Catalytic Activity of the SMYD Family Lysine Methyltransferase Set5.

Authors:  Deepika Jaiswal; Rashi Turniansky; James J Moresco; Sabeen Ikram; Ganesh Ramaprasad; Assefa Akinwole; Julie Wolf; John R Yates; Erin M Green
Journal:  Mol Cell Biol       Date:  2020-01-03       Impact factor: 4.272

4.  RB1 methylation by SMYD2 enhances cell cycle progression through an increase of RB1 phosphorylation.

Authors:  Hyun-Soo Cho; Shinya Hayami; Gouji Toyokawa; Kazuhiro Maejima; Yuka Yamane; Takehiro Suzuki; Naoshi Dohmae; Masaharu Kogure; Daechun Kang; David E Neal; Bruce A J Ponder; Hiroki Yamaue; Yusuke Nakamura; Ryuji Hamamoto
Journal:  Neoplasia       Date:  2012-06       Impact factor: 5.715

5.  Cardiac deletion of Smyd2 is dispensable for mouse heart development.

Authors:  Florian Diehl; Mark A Brown; Machteld J van Amerongen; Tatyana Novoyatleva; Astrid Wietelmann; June Harriss; Fulvia Ferrazzi; Thomas Böttger; Richard P Harvey; Philip W Tucker; Felix B Engel
Journal:  PLoS One       Date:  2010-03-17       Impact factor: 3.240

6.  Crystal structures of histone and p53 methyltransferase SmyD2 reveal a conformational flexibility of the autoinhibitory C-terminal domain.

Authors:  Yuanyuan Jiang; Nualpun Sirinupong; Joseph Brunzelle; Zhe Yang
Journal:  PLoS One       Date:  2011-06-28       Impact factor: 3.240

7.  Smyd3 is required for the development of cardiac and skeletal muscle in zebrafish.

Authors:  Tomoaki Fujii; Shin-ichiro Tsunesumi; Kiyoshi Yamaguchi; Sumiko Watanabe; Yoichi Furukawa
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

8.  Smyd1 facilitates heart development by antagonizing oxidative and ER stress responses.

Authors:  Tara L Rasmussen; Yanlin Ma; Chong Yon Park; June Harriss; Stephanie A Pierce; Joseph D Dekker; Nicolas Valenzuela; Deepak Srivastava; Robert J Schwartz; M David Stewart; Haley O Tucker
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

9.  SMYD1, the myogenic activator, is a direct target of serum response factor and myogenin.

Authors:  Dali Li; Zhiyv Niu; Weishi Yu; Yu Qian; Qian Wang; Qiang Li; Zhengfang Yi; Jian Luo; Xiushan Wu; Yuequn Wang; Robert J Schwartz; Mingyao Liu
Journal:  Nucleic Acids Res       Date:  2009-11       Impact factor: 16.971

10.  Mouse myofibers lacking the SMYD1 methyltransferase are susceptible to atrophy, internalization of nuclei and myofibrillar disarray.

Authors:  M David Stewart; Suhujey Lopez; Harika Nagandla; Benjamin Soibam; Ashley Benham; Jasmine Nguyen; Nicolas Valenzuela; Harry J Wu; Alan R Burns; Tara L Rasmussen; Haley O Tucker; Robert J Schwartz
Journal:  Dis Model Mech       Date:  2016-03       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.